MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and MitoxantroneISRN Neurology, 2013
- B cell exchange across the blood-brain barrier in multiple sclerosisJournal of Clinical Investigation, 2012
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosisJournal of Neuroimmunology, 2009
- CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndromeJournal of Neuroimmunology, 2008
- Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MSJournal of Neuroimmunology, 2007
- Pharmacological Properties, Toxicology and Scientific Rationale for the use of Natalizumab (Tysabri®) in Inflammatory DiseasesCNS Drug Reviews, 2007
- Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selectionJournal of Neuroimmunology, 2007
- Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.Journal of Clinical Investigation, 1998
- Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.Journal of Neurology, Neurosurgery & Psychiatry, 1994